Cannabidiol
augmentor
Summary
"Cannabidiol, also known as CBD, is an antipsychotic cannabinoid found in the hemp plant Cannabis sativa...CBD alone is not intoxicating, but it appears to affect the euphoric effect of THC (which is an isomer of cannabidiol) and add a sedative quality...Medically, it appears to relieve convulsion, inflammation, anxiety, and nausea, as well as inhibit cancer cell growth."
“Cannabidiol - Wikidoc.” Wikidoc.org, 2012, www.wikidoc.org/index.php/Cannabidiol.
Benefits
1.
May improve symptoms of anxiety by increasing serotonin transmission [1]
2.
Reduces withdrawal symptoms caused by dopamine dysregulation [2]
3.
Improves the efficacy of THC while reducing/preventing psychotic side-effects such as anxiety and paranoia [3]
Deficiency Factors
Access a list of other supplements that enhance the benefits of when you signup for a support plan.
Applications & Precautions
ApplicationsAlcohol Detox, Caffeine Detox, Sugar Detox
Precautions
Taking large doses of CBD can lead to drowsiness, especially late in the day.
Dosage Guidelines
25
50
mg
25
mg
150
mg
sublingually
Recommended Products
CBD Oil 1000 mg - Irwin Naturals
Order from Irwin Naturals
CBD Full Spectrum 20 MG - Plnt
Order from Vitamin Shoppe
See a list of verified product recommendations for when you signup for a support plan.
References
1.
De Gregorio, Danilo, et al. “Cannabidiol Modulates Serotonergic Transmission and Reverses Both Allodynia and Anxiety-like Behavior in a Model of Neuropathic Pain.” Pain, vol. 160, no. 1, 27 Aug. 2018, pp. 136–150, www.ncbi.nlm.nih.gov/pmc/articles/PMC6319597/, 10.1097/j.pain.0000000000001386.
2.
Seeman, P. “Cannabidiol Is a Partial Agonist at Dopamine D2High Receptors, Predicting Its Antipsychotic Clinical Dose.” Translational Psychiatry, vol. 6, no. 10, Oct. 2016, pp. e920–e920, www.ncbi.nlm.nih.gov/pmc/articles/PMC5315552/, 10.1038/tp.2016.195.
3.
Hudson, Roger, et al. “Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation.” The Journal of Neuroscience, vol. 39, no. 44, 30 Sept. 2019, pp. 8762–8777, www.jneurosci.org/content/39/44/8762, 10.1523/jneurosci.0708-19.2019.
Legend
Get Started
